Buscar
-
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
(Drugs, 2023-12-21)Article de revue -
Longitudinal investigation of patients receiving involuntary treatment for extremely severe anorexia nervosa
(European Eating Disorders Review, 2023-09-10)Article de revue -
Microstructural Gray Matter Integrity Deteriorates After an Ischemic Stroke and Is Associated with Processing Speed
(Translational stroke research. vol. 14, n° 2, pp. 185-192, 2023-04-14)Article de revue -
Discovery of a new type of neuroimmune interaction in the aged brain's response to energy surfeit
(Brain, Behavior, and Immunity. vol. 110, pp. 288-289, 2023-05)Article de revue -
Analysis of steroid profiles by mass spectrometry: A new tool for exploring adrenal tumors?
(Annales d'Endocrinologie. vol. 82, n° 1, pp. 36-42, 2021-02)Article de revue -
Characterization of Kisspeptin Neurons in the Human Rostral Hypothalamus
(Neuroendocrinology. vol. 111, n° 3, pp. 249-262, 2021)Article de revue -
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort
(Progress in Neuro-Psychopharmacology and Biological Psychiatry. vol. 101, pp. 109927, 2020-07-13)Article de revue -
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Non-invasive Diagnostic Strategy in ACTH-dependent Cushing’s Syndrome
(Journal of Clinical Endocrinology and Metabolism. vol. 105, n° 10, pp. 3273-3284, 2020-10-01)Article de revue -
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
(Journal of Endocrinological Investigation, 2023-11-04)Article de revue